TrialJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2017

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.

Patricia Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.